Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating topical imipramine and topical amitriptyline to reduce UVB-induced redness in rosacea, and the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine (imipramine)
  • amitriptyline (amitriptyline)

Snippet

Sponsor: Wright State University | Conditions: Rosacea | Phase 2 | Status: RECRUITING